Nancy Krunic | VP, Global Head of Future Precision Medicine
Novartis Oncology

Nancy Krunic, VP, Global Head of Future Precision Medicine, Novartis Oncology

Dr. Krunic leads a Center of Excellence within the Novartis Global Drug Development organization and is responsible for advancing precision medicine across clinical development programs through the integration of in vitro, in vivo and in silico technologies.  Accountable for the precision medicine technology strategy, Dr. Krunic leverages a deep understanding of both drug and diagnostic development, health authority approval and global commercialization processes.  Her broad experience with innovative technologies used across several disease areas for the detection and analysis of biomarkers has been honed through her academic training at the University of Toronto and roles of increasing responsibilities at Leo Pharma, Luminex and Novartis.

Appearances:



Precision 2018 Day 1 @ 09:50

Keynote panel: How is precision medicine shaping healthcare and medicine?

  • Diagnostics – defining tumours
  • Liquid biopsies - mapping cancers
  • Targeted drugs
  • Data mining

Precision 2018 Day 2 @ 14:30

Enabling real time oncology through the deployment of disruptive technologies

  • Apply the right biology
  • Leverage innovative technology
  • Analyse data rigorously

back to speakers